Faculty Opinions recommendation of EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1016183.222430 ◽

2004 ◽

Author(s):

Charles Streuli

Keyword(s):

Lung Cancer ◽

Clinical Response ◽

Download Full-text

Faculty Opinions recommendation of EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1016183.258643 ◽

2004 ◽

Author(s):

Charles Brenner

Keyword(s):

Lung Cancer ◽

Clinical Response ◽

Download Full-text

Faculty Opinions recommendation of EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1016183.217465 ◽

2004 ◽

Author(s):

Joachim Herz

Keyword(s):

Lung Cancer ◽

Clinical Response ◽

Download Full-text

Faculty Opinions recommendation of EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1016183.14725081 ◽

2011 ◽

Author(s):

Ruth Palmer

Keyword(s):

Lung Cancer ◽

Clinical Response ◽

Download Full-text

EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

Science ◽

10.1126/science.1099314 ◽

2004 ◽

Vol 304 (5676) ◽

pp. 1497-1500 ◽

Cited By ~ 6656

Author(s):

J. G. Paez

Keyword(s):

Lung Cancer ◽

Clinical Response ◽

Download Full-text

EGFR Mutations in Lung Cancer: Correlation With Clinical Response to Gefitinib Therapy

Yearbook of Pulmonary Disease ◽

10.1016/s8756-3452(08)70092-6 ◽

2006 ◽

Vol 2006 ◽

pp. 112-114 ◽

Author(s):

L.T. Tanoue

Keyword(s):

Lung Cancer ◽

Clinical Response ◽

Download Full-text

Faculty Opinions recommendation of EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1016183.242487 ◽

2004 ◽

Author(s):

Alfred Wittinghofer

Keyword(s):

Lung Cancer ◽

Clinical Response ◽

Download Full-text

Faculty Opinions recommendation of EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1016183.212479 ◽

2004 ◽

Author(s):

William Kaelin

Keyword(s):

Lung Cancer ◽

Clinical Response ◽

Download Full-text

Faculty Opinions recommendation of EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1016183.214480 ◽

2004 ◽

Author(s):

Patricia C Weber

Keyword(s):

Lung Cancer ◽

Clinical Response ◽

Download Full-text

Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70398-5 ◽

2006 ◽

Vol 2006 ◽

pp. 133-134

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Egfr Mutations ◽

Apoptotic Pathways

Download Full-text

Clinical validation of a sensitive real-time PCR assay for detecting EGFR mutations in plasma ctDNA from patients with non-small cell lung cancer

10.26226/morressier.5b4709856f4cb300109519aa ◽

2018 ◽

Author(s):

Guanshan Zhu

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Real Time ◽

Cell Lung Cancer ◽

Real Time Pcr ◽

Egfr Mutations ◽

Clinical Validation ◽

Small Cell Lung ◽

Download Full-text